Claudio Maffeis Selected Research

Claudio Maffeis Research Topics

Disease

24	Insulin Resistance 09/2022 - 01/2002
24	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2012
23	Obesity 10/2022 - 12/2007
16	Overweight 10/2022 - 01/2006
10	Type 2 Diabetes Mellitus (MODY) 10/2022 - 04/2011
9	Hypertension (High Blood Pressure) 12/2020 - 01/2013
7	Non-alcoholic Fatty Liver Disease 09/2022 - 12/2011
7	Inflammation (Inflammations) 01/2022 - 12/2007
5	Glucose Intolerance 01/2021 - 07/2010
4	Prediabetic State (Prediabetes) 01/2021 - 10/2019
4	Body Weight (Weight, Body) 01/2020 - 01/2003
3	Fatty Liver 10/2022 - 03/2019
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 03/2019
2	Liver Diseases (Liver Disease) 09/2022 - 10/2019
2	Fibrosis (Cirrhosis) 09/2022 - 11/2020
2	COVID-19 01/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2022
2	Diabetes Complications 07/2021 - 01/2021
2	Hyperglycemia 07/2021 - 01/2021
2	Dyslipidemias (Dyslipidemia) 12/2019 - 01/2019
2	Diabetes Mellitus 07/2017 - 08/2016
2	Hypertriglyceridemia 02/2017 - 01/2013
1	Weight Loss (Weight Reduction) 01/2022
1	Morbid Obesity 01/2022
1	Anemia 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2021
1	Albuminuria 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Refractive Errors (Refractive Error) 11/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020
1	Ganglion Cysts (Ganglion) 11/2020
1	Chronic Renal Insufficiency 01/2020
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020

Drug/Important Bio-Agent (IBA)

38	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2002
18	Insulin (Novolin)FDA Link 09/2022 - 01/2006
10	LipidsIBA 01/2021 - 02/2012
8	Triglycerides (Triacylglycerol)IBA 10/2022 - 07/2010
8	HDL CholesterolIBA 01/2021 - 07/2010
6	CarbohydratesIBA 01/2022 - 12/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
5	AdiponectinIBA 09/2022 - 06/2008
4	Uric Acid (Urate)IBA 10/2022 - 07/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2021 - 12/2019
3	LDL CholesterolIBA 01/2021 - 01/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 09/2017
3	C-Reactive ProteinIBA 02/2013 - 06/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013 - 12/2007
2	Biological ProductsIBA 01/2022 - 12/2007
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 10/2019
2	FructoseIBA 01/2022 - 07/2016
2	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2022 - 09/2021
2	Dietary Fiber FDA Link 09/2021 - 12/2015
2	CreatinineIBA 01/2021 - 01/2021
2	Dietary Fats (Dietary Fat)IBA 01/2021 - 03/2012
2	Palmitic Acid (Hexadecanoic Acid)IBA 05/2020 - 03/2019
2	CholesterolIBA 01/2020 - 01/2012
2	antiarrhythmic peptide (AAP)IBA 01/2020 - 01/2020
2	Vitamin D FDA LinkGeneric 10/2019 - 04/2014
2	FatsIBA 09/2017 - 12/2015
2	LeptinIBA 02/2013 - 06/2008
2	AdipokinesIBA 02/2013 - 06/2008
2	oxidized low density lipoproteinIBA 03/2012 - 01/2012
2	GhrelinIBA 01/2007 - 01/2006
1	HDL LipoproteinsIBA 10/2022
1	zonulinIBA 10/2022
1	Liraglutide FDA Link 01/2022
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Kruppel-Like Factor 6IBA 01/2022
1	Unsaturated FatsIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	CeramidesIBA 01/2022
1	Starch (Cornstarch)IBA 09/2021
1	SugarsIBA 09/2021
1	SteroidsIBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	AlbuminsIBA 01/2021
1	CD40 Ligand (CD40L)IBA 12/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020
1	C-PeptideIBA 12/2020
1	Peroxidase (Myeloperoxidase)IBA 12/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2020
1	MicroRNAs (MicroRNA)IBA 12/2020
1	ResistinIBA 12/2020
1	OsteoprotegerinIBA 12/2020
1	Bile Acids and Salts (Bile Acids)IBA 11/2020
1	Retinaldehyde (Retinal)IBA 11/2020
1	palmitoleic acidIBA 05/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	AntioxidantsIBA 01/2020

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2006
7	Glycemic Control 09/2021 - 03/2012
2	Ambulatory Care (Outpatient Care) 09/2022 - 11/2020
1	Bariatric Surgery 01/2022
1	Nutrition Therapy (Medical Nutrition Therapy) 07/2021
1	Secondary Prevention 01/2021